| Title： | Guidelines for diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus in China |
| Edition： | Updated |
| Classification： | Standard guideline |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | clinician |
| Evidence classification method： | Ia Evidences are originated from the meta-analysis results of various RCTs Ib Evidences are originated from the results of at least one well-designed RCT IIa Evidences are originated from the results of at least one well-designed perspective non-RCT IIb Evidences are originated from the results of at least one well-designed interventional clinical research of other type III Evidences are originated from the well-designed non-interventional clinical researches, such as descriptive researches and relevant researches IV Evidences are originated from the reports made by committee of experts or the clinical reports of authoritative experts |
| Development unit： | China Association of Liver Cancer |
| Registration time: | 2022-02-22 |
| Registration number： | IPGRP-2022CN081 |
| Purpose of the guideline: | To standardize the diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus |
Latest registration
